BF: Artificial Nipple and Duration of Breastfeeding (2008)

Citation:

Blomquist HK, Jonesbo F, Serenius F, Persson LA. Supplementary feeding in the maternity ward shortens the duration of breastfeeding. Acta Paediatrics 1994; 83: 1,122-1,126.

PubMed ID: 7841722
 
Study Design:
Prospective Cohort Study
Class:
B - Click here for explanation of classification scheme.
Quality Rating:
Positive POSITIVE: See Quality Criteria Checklist below.
Research Purpose:

The aim of this prospective observational study was to elucidate the feeding routines at a maternity unit and to analyze the risk of not being breast fed at three months of age in relation to feeding patterns in the early neonatal period, while simultaneously taking into account a number of characteristics of the mother and child.

Inclusion Criteria:

During the period from February to April 1990, 583 children were born at the University Hospital, Umeå, Sweden. 521 children (243 boys and 278 girls) born at the hospital were included in the study. One-quarter of the children received supplementary feeds on the third day of life, the indications for this being birth weight less than 3.0kg, maternal diabetes or gestational diabetes, “insufficient amounts of milk” or fussiness.

Exclusion Criteria:

53 children who were treated entirely in the neonatal ward and the nine others who were discharged to other hospitals were excluded from the study.

Description of Study Protocol:

Design

Prospective Cohort Study

 

Statistical Analysis

  • The relative risks of not being breast-fed at three months of age were estimated by calculation of odds ratios (OR) and confidence limits (CL)
  • When simultaneous adjustments were made for several potential confounders, multiple logistic regression analysis was used using EGRET software program.
Data Collection Summary:

Timing of Measurements

  • Information regarding pregnancy, delivery and early neonatal feeding was registered by the maternity unit staff and cross-checked by a pediatrician when the mother and baby were discharged from the hospital
  • A questionnaire regarding feeding patterns at one, two, three and four months was prospectively completed by the parents
  • Missing information was obtained by telephone interviews
  • One-quarter of the children received supplementary feeds on the third day of life, the indications for this being birth weight less than 3.0kg, maternal diabetes or gestational diabetes, “insufficient amounts of milk” or fussiness.

Dependent Variables

 

  • Exclusively breast-fed: Infant received only breast milk from its mother, or expressed breast milk, and no other liquids or solids, with the exception of drops or syrup containing vitamins, mineral supplements or medicines
  • Breast-fed: Infant received breast milk, but was not allowed to receive any food or liquid including non-human milk
  • Supplementary donor’s milk: Infant received human milk from the pooled milk bank.

 

Independent Variables

 

  • Mother’s age (years)
  • Mother smoking
  • Earlier births
  • Delivery
  • Gestational age (weeks)
  • Birth weight (g)
  • Sex
  • Admitted neonatal ward initially
  • Supplementary feeding
  • Used breast  pump
  • Used oxytocin spray
  • Weight loss >=10%.

Control Variables

 All independent variables were in multiple logistic regression model.

Description of Actual Data Sample:

 

Initial N

583

Attrition (final N)

521 children (243 boys and 278 girls). Note: Feeding information after the neonatal period were missing in 6%.

Age

See table 2

Ethnicity

Not described

Other relevant demographics

Location

Umea, Sweden

 

Summary of Results:

The indications for pediatricians to prescribe supplementary feeding are listed in Table 1. During the first day, maternal diabetes or gestational diabetes were major reasons, while a pronounced initial weight loss dominated after a few days. Man children received supplementary donor’s milk or formula for no specific reasons, sometimes indicated as “insufficient amounts of milk”

Table 1: Proportion of children receiving supplementary donor’s milk or formula in relation to different indications (percentage of total number of children for each day).

Day
Indication 1 2 3 4 5 6
Birth weight<3kg 2.9 4.7  5.5  3.2  1.9  0.0 
Birth weight>4.5kg 0.2 0.4 0.4 0.4  0.2  0.9 
Initial weight loss 0.0 0.2 1.6 4.4  2.6  0.9 
Maternal diabetes or gestational diabetes 5.7  6.0  5.5  3.6  1.4  0.9 
Jitteriness 0.2 1.0  1.2  0.4  0.0  0.0 
Fussiness 0.4 1.4  2.3  1.2  0.5  0.9 
Insufficient amount of milk 2.0 2.1  3.7  3.4  5.6  8.4 
Other, unknown 1.2 1.8  2.2  2.4  2.8  6.7 
Percent of children receiving supplementary feeding 12.5 17.5 22.3 18.6  15.0  18.7 
Total number of children in the maternity unita
511 513  511  505 426  225

 a 35 children were partly treated in the neonatal unit, usually the first one to two days.

In the bi-variate analysis, an increased risk of not being breast-fed at three months was related to young maternal age, smoking, Cesarean section, supplementation with door’s milk or formula at the maternity unit, the use of oxytocin spray and an initial weight loss ≥10% of birth weight.

Table 2: Relative risk of not being breast fed at three months in relation to early feeding characteristics of the mother, the delivery and the child.

Characteristics

 
Non-breast fed
Breast-fed
OR
95% CL

Mother’s age (years)

25-
72
336
1.0
 
 
<25
25
57
2.05
1.21-3.47
Mother’s Smoking
no
61
309
1.0
 
 
yes
35
56
3.17
1.94-5.16
Earlier births
Yes
60
253
1.0
 
 
No
37
139
1.12
0.71-1.78
Delivery
Vaginal
82
366
1.0
 
 
Caesarean
14
22
2.84
1.43-5.65
Gestational age (weeks)
38-
83
347
1.0
 
 
<38
11
28
1.64
0.79-3.42
Birth weight (g)
<3,000
13
48
1.0
 
 
3,000-4,499
83
337
0.91
0.47-1.76
 
4,500-
2
9
0.82
0.16-4.31
Sex
Boy
49
184
1.0
 
 
Girl
49
210
0.88
0.56-1.36
Admitted neonatal ward initially
No
88
372
1.0
 
 
Yes
10
22
1.92
0.89-4.16
Supplementary feeding
No
44
292
1.0
 
 
Yes
54
102
3.51
2.26-5.47
Used breast pump
No
64
284
1.0
 
 
Yes
33
108
1.36
0.84-2.18
Used oxytocin spray
No
74
348
1.0
 
 
Yes
24
46
2.45
1.43-4.22
Weight loss>=10%
No
70
345
1.0
 
 
Yes
23
40
2.83
1.62-4.95
 

Many of these factors in Table 2 are associated with each other. In order to control for confounding, multiple logistic regression including all factors in Table 2 were performed. After adjustment there was a significant independent increased risk of not being breast-fed at three months in relationship to maternal age (<25 years OR 4.2, 95% CL 2.0-8.5), maternal smoking (OR 4.0, 95% CL 2.1-7.4), neonatal feeding (supplements OR 3.9,95% CL 2.1-7.2) and initial weight loss ≥10% OR 2.8, 95% CL 1.4-5.8).

 

Other Findings

The relative risk of not being breast fed at three months in relation to feeding in the maternity unit and initial weight loss(reference group=those exclusively breast fed with an initial weight loss of less than 10% of birth weight, OR 1.0) was analyzed.

There was an interaction between initial weight loss and feeding pattern at the maternity unit and the risk of not being breast-fed at three months. The risk of not being breast-fed was almost seven times higher for infants who were supplemented and had an initial weight loss >=10% of birth weight, compared with unsupplemented infants with less weight loss.

Author Conclusion:
  • Giving supplementary donor’s milk or formula during early neonatal period increased the risk of a short duration of breastfeeding even after adjustment for initial weight loss and other factors examined
  • Supplementary feeding in the maternity unit was associated with an increased risk of early cessation of breastfeeding. The authors recommended that supplementary feeding be given with greater restrictively to healthy newborn children.

 

Limitations

The question explored by the researchers was whether the association shown between supplementation in the maternity unit and a shorter duration of breast feeding was casual or spurious. A number of confounding factors were considered in the analysis, characterizing the mother and child.

  • Maternal education which has been shown to be associated with breastfeeding was not included in the analysis; smoking, a factor strongly associated with education was examined
  • The association between supplementation and non-breastfeeding was not weakened but became stronger when the different potential confounders were accounted for. This may have indicated a casual relationship; however, the mother’s confidence and willingness to continue breastfeeding was not assessed.
  • The supplements were planned to be prescribed by pediatricians but some children received supplementation for no declared reason
  • The routines for supplementation were rather liberal and were later revised in accordance with international recommendations.

 

Funding Source:
Reviewer Comments:

Analytical longitudinal surveys refer to what epidemiologists term prospective or cohort studies. A Cohort Study is a study in which patients who presently have a certain condition and/or receive a particular treatment are followed over time and compared with another group who are not affected by the condition under investigation. Studies of this kind provide a better opportunity than one-time cross-sectional studies to examine whether certain behaviors do in fact lead to (or cause) the disease.            

The limitations and critique of the study, as stated by the authors appear to be very appropriate.

 

 

Quality Criteria Checklist: Primary Research
Relevance Questions
  1. Would implementing the studied intervention or procedure (if found successful) result in improved outcomes for the patients/clients/population group? (Not Applicable for some epidemiological studies) Yes
  2. Did the authors study an outcome (dependent variable) or topic that the patients/clients/population group would care about? Yes
  3. Is the focus of the intervention or procedure (independent variable) or topic of study a common issue of concern to dieteticspractice? Yes
  4. Is the intervention or procedure feasible? (NA for some epidemiological studies) Yes
 
Validity Questions
1. Was the research question clearly stated? Yes
  1.1. Was (were) the specific intervention(s) or procedure(s) [independent variable(s)] identified? Yes
  1.2. Was (were) the outcome(s) [dependent variable(s)] clearly indicated? Yes
  1.3. Were the target population and setting specified? Yes
2. Was the selection of study subjects/patients free from bias? Yes
  2.1. Were inclusion/exclusion criteria specified (e.g., risk, point in disease progression, diagnostic or prognosis criteria), and with sufficient detail and without omitting criteria critical to the study? Yes
  2.2. Were criteria applied equally to all study groups? Yes
  2.3. Were health, demographics, and other characteristics of subjects described? Yes
  2.4. Were the subjects/patients a representative sample of the relevant population? Yes
3. Were study groups comparable? Yes
  3.1. Was the method of assigning subjects/patients to groups described and unbiased? (Method of randomization identified if RCT) N/A
  3.2. Were distribution of disease status, prognostic factors, and other factors (e.g., demographics) similar across study groups at baseline? N/A
  3.3. Were concurrent controls or comparisons used? (Concurrent preferred over historical control or comparison groups.) N/A
  3.4. If cohort study or cross-sectional study, were groups comparable on important confounding factors and/or were preexisting differences accounted for by using appropriate adjustments in statistical analysis? Yes
  3.5. If case control study, were potential confounding factors comparable for cases and controls? (If case series or trial with subjects serving as own control, this criterion is not applicable.) N/A
  3.6. If diagnostic test, was there an independent blind comparison with an appropriate reference standard (e.g., "gold standard")? N/A
4. Was method of handling withdrawals described? Yes
  4.1. Were follow-up methods described and the same for all groups? Yes
  4.2. Was the number, characteristics of withdrawals (i.e., dropouts, lost to follow up, attrition rate) and/or response rate (cross-sectional studies) described for each group? (Follow up goal for a strong study is 80%.) Yes
  4.3. Were all enrolled subjects/patients (in the original sample) accounted for? Yes
  4.4. Were reasons for withdrawals similar across groups? N/A
  4.5. If diagnostic test, was decision to perform reference test not dependent on results of test under study? N/A
5. Was blinding used to prevent introduction of bias? ???
  5.1. In intervention study, were subjects, clinicians/practitioners, and investigators blinded to treatment group, as appropriate? N/A
  5.2. Were data collectors blinded for outcomes assessment? (If outcome is measured using an objective test, such as a lab value, this criterion is assumed to be met.) ???
  5.3. In cohort study or cross-sectional study, were measurements of outcomes and risk factors blinded? No
  5.4. In case control study, was case definition explicit and case ascertainment not influenced by exposure status? N/A
  5.5. In diagnostic study, were test results blinded to patient history and other test results? N/A
6. Were intervention/therapeutic regimens/exposure factor or procedure and any comparison(s) described in detail? Were interveningfactors described? Yes
  6.1. In RCT or other intervention trial, were protocols described for all regimens studied? N/A
  6.2. In observational study, were interventions, study settings, and clinicians/provider described? Yes
  6.3. Was the intensity and duration of the intervention or exposure factor sufficient to produce a meaningful effect? N/A
  6.4. Was the amount of exposure and, if relevant, subject/patient compliance measured? N/A
  6.5. Were co-interventions (e.g., ancillary treatments, other therapies) described? N/A
  6.6. Were extra or unplanned treatments described? N/A
  6.7. Was the information for 6.4, 6.5, and 6.6 assessed the same way for all groups? N/A
  6.8. In diagnostic study, were details of test administration and replication sufficient? N/A
7. Were outcomes clearly defined and the measurements valid and reliable? Yes
  7.1. Were primary and secondary endpoints described and relevant to the question? Yes
  7.2. Were nutrition measures appropriate to question and outcomes of concern? Yes
  7.3. Was the period of follow-up long enough for important outcome(s) to occur? Yes
  7.4. Were the observations and measurements based on standard, valid, and reliable data collection instruments/tests/procedures? Yes
  7.5. Was the measurement of effect at an appropriate level of precision? Yes
  7.6. Were other factors accounted for (measured) that could affect outcomes? Yes
  7.7. Were the measurements conducted consistently across groups? Yes
8. Was the statistical analysis appropriate for the study design and type of outcome indicators? Yes
  8.1. Were statistical analyses adequately described and the results reported appropriately? Yes
  8.2. Were correct statistical tests used and assumptions of test not violated? Yes
  8.3. Were statistics reported with levels of significance and/or confidence intervals? Yes
  8.4. Was "intent to treat" analysis of outcomes done (and as appropriate, was there an analysis of outcomes for those maximally exposed or a dose-response analysis)? Yes
  8.5. Were adequate adjustments made for effects of confounding factors that might have affected the outcomes (e.g., multivariate analyses)? Yes
  8.6. Was clinical significance as well as statistical significance reported? Yes
  8.7. If negative findings, was a power calculation reported to address type 2 error? N/A
9. Are conclusions supported by results with biases and limitations taken into consideration? Yes
  9.1. Is there a discussion of findings? Yes
  9.2. Are biases and study limitations identified and discussed? Yes
10. Is bias due to study's funding or sponsorship unlikely? Yes
  10.1. Were sources of funding and investigators' affiliations described? Yes
  10.2. Was the study free from apparent conflict of interest? Yes